A multi-docking strategy for robotic LAR and deep pelvic surgery with the Hugo RAS system: experience from a tertiary referral center.


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
01 Oct 2024
Historique:
accepted: 17 09 2024
medline: 1 10 2024
pubmed: 1 10 2024
entrez: 30 9 2024
Statut: epublish

Résumé

In June 2023, our institution adopted the Medtronic Hugo RAS system for colorectal procedures. This system's independent robotic arms enable personalized docking configurations. This study presents our refined multi-docking strategy for robotic low anterior resection (LAR) and deep pelvic procedures, designed to maximize the Hugo RAS system's potential in rectal surgery, and evaluates the associated learning curve. This retrospective analysis included 31 robotic LAR procedures performed with the Hugo RAS system using our novel multi-docking strategy. Docking times were the primary outcome. The Mann-Kendall test, Spearman's correlation, and cumulative sum (CUSUM) analysis were used to assess the learning curve and efficiency gains associated with the strategy. Docking times showed a significant negative trend (p < 0.01), indicating improved efficiency with experience. CUSUM analysis confirmed a distinct learning curve, with proficiency achieved around the 15th procedure. The median docking time was 6 min, comparable to other robotic platforms after proficiency. This study demonstrates the feasibility and effectiveness of a multi-docking strategy in robotic LAR using the Hugo RAS system. Our personalized approach, capitalizing on the system's unique features, resulted in efficient docking times and streamlined surgical workflow. This approach may be particularly beneficial for surgeons transitioning from laparoscopic to robotic surgery, facilitating a smoother adoption of the new technology. Further research is needed to validate the generalizability of these findings across different surgical settings and experience levels.

Identifiants

pubmed: 39349880
doi: 10.1007/s00384-024-04728-2
pii: 10.1007/s00384-024-04728-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

154

Subventions

Organisme : European Union - NextGeneration EU
ID : CUP J33C22002920006
Organisme : European Union - NextGeneration EU
ID : CUP J33C22002920006

Informations de copyright

© 2024. The Author(s).

Références

You YN, Hardiman KM, Bafford A et al (2020) The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of rectal cancer. Dis Colon Rectum 63(9):1191–1222. https://doi.org/10.1097/dcr.0000000000001762
doi: 10.1097/dcr.0000000000001762 pubmed: 33216491
Affleck AGT, Herzig D (2024) Total neoadjuvant therapy for rectal cancer. Surg Clin North Am 104(3):609–617. https://doi.org/10.1016/j.suc.2023.11.010
doi: 10.1016/j.suc.2023.11.010 pubmed: 38677824
Benson AB, Venook AP, Al-Hawary MM et al (2022) Rectal cancer, version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 20(10):1139–1167. https://doi.org/10.6004/jnccn.2022.0051
doi: 10.6004/jnccn.2022.0051 pubmed: 36240850
Feeney G, Sehgal R, Sheehan M, Hogan A, Regan M, Joyce M, Kerin M (2019) Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol 25(33):4850–4869. https://doi.org/10.3748/wjg.v25.i33.4850
doi: 10.3748/wjg.v25.i33.4850 pubmed: 31543678 pmcid: 6737323
Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1(8496):1479–1482. https://doi.org/10.1016/s0140-6736(86)91510-2
doi: 10.1016/s0140-6736(86)91510-2 pubmed: 2425199
Nussbaum DP, Speicher PJ, Ganapathi AM, Englum BR, Keenan JE, Mantyh CR, Migaly J (2015) Laparoscopic versus open low anterior resection for rectal cancer: results from the national cancer data base. J Gastrointest Surg19(1):124–31; discussion 131–2. https://doi.org/10.1007/s11605-014-2614-1
Zhou ZG, Hu M, Li Y et al (2004) Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer. Surg Endosc 18(8):1211–1215. https://doi.org/10.1007/s00464-003-9170-1
doi: 10.1007/s00464-003-9170-1 pubmed: 15457380
Schietroma M, Romano L, Apostol AI, Vada S, Necozione S, Carlei F, Giuliani A (Jan2022) Mid- and low-rectal cancer: laparoscopic vs open treatment-short- and long-term results. Meta-analysis of randomized controlled trials. Int J Colorectal Dis. 37(1):71–99. https://doi.org/10.1007/s00384-021-04048-9
doi: 10.1007/s00384-021-04048-9 pubmed: 34716474
Yang S, Lin Y, Zhong W et al (2023) Effect of laparoscopic versus open surgery on postoperative wound complications in patients with low rectal cancer: a meta-analysis. Int Wound J 21(3):e14471. https://doi.org/10.1111/iwj.14471
doi: 10.1111/iwj.14471 pubmed: 37935425 pmcid: 10898391
Jiang WZ, Xu JM, Xing JD et al (2022) Short-term outcomes of laparoscopy-assisted vs open surgery for patients with low rectal cancer: the LASRE randomized clinical trial. JAMA Oncol 8(11):1607–1615. https://doi.org/10.1001/jamaoncol.2022.4079
doi: 10.1001/jamaoncol.2022.4079 pubmed: 36107416 pmcid: 9478880
Ferrari D, Violante T, Novelli M, Starlinger PP, Smoot RL, Reisenauer JS, Larson DW (2024) The death of laparoscopy. Surg Endosc 38(5):2677–2688. https://doi.org/10.1007/s00464-024-10774-2
doi: 10.1007/s00464-024-10774-2 pubmed: 38519609
Achilli P, Grass F, Larson DW (2021) Robotic surgery for rectal cancer as a platform to build on: review of current evidence. Surg Today 51(1):44–51. https://doi.org/10.1007/s00595-020-02008-4
doi: 10.1007/s00595-020-02008-4 pubmed: 32367173
Ferrari D, Violante T, Addison P et al (2024) Robotic resection of presacral tumors. Tech Coloproctol 28(1):49. https://doi.org/10.1007/s10151-024-02922-6
doi: 10.1007/s10151-024-02922-6 pubmed: 38653930
Crippa J, Grass F, Dozois EJ et al (2021) Robotic surgery for rectal cancer provides advantageous outcomes over laparoscopic approach: results from a large retrospective cohort. Ann Surg 274(6):e1218–e1222. https://doi.org/10.1097/sla.0000000000003805
doi: 10.1097/sla.0000000000003805 pubmed: 32068552
Quezada N, Irarrazaval MJ, Chen DC, Grimoldi M, Pimentel F, Crovari F (2024) Robotic transversus abdominis release using HUGO RAS system: our initial experience. Surg Endosc 38(6):3395–3404. https://doi.org/10.1007/s00464-024-10865-0
doi: 10.1007/s00464-024-10865-0 pubmed: 38719985
Caputo D, Cammarata R, Farolfi T, Coppola R, La Vaccara V (2024) First worldwide report on rectal resections with Hugo™ surgical system: description of docking angles and tips for an effective setup. ANZ J Surg. https://doi.org/10.1111/ans.18918
doi: 10.1111/ans.18918 pubmed: 38553884
Poggioli G, Rottoli M (2019) Surgical treatment of ulcerative colitis: laparoscopy and new minimally invasive techniques. In: Poggioli G, ed. Ulcerative Colitis. Springer Milan, pp 139–153
Bae SU, Baek SJ, Hur H, Baik SH, Kim NK, Min BS (2015) Robotic left colon cancer resection: a dual docking technique that maximizes splenic flexure mobilization. Surgical Endoscopy 29(6):1303–1309. https://doi.org/10.1007/s00464-014-3805-2
doi: 10.1007/s00464-014-3805-2 pubmed: 25159646
Loaec C, Bats AS, Ngo C et al (2018) Dual docking robotic surgical staging for high risk endometrial cancer. Eur J Obstet Gynecol Reprod Biol 225:79–83. https://doi.org/10.1016/j.ejogrb.2018.04.009
doi: 10.1016/j.ejogrb.2018.04.009 pubmed: 29679815
Franké O, Narducci F, Chereau-Ewald E et al (2015) Role of a double docking to improve lymph node dissection: when robotically assisted laparoscopy for para-aortic lymphadenectomy is associated to a pelvic procedure. Int J Gynecol Cancer 25(2):331–336. https://doi.org/10.1097/igc.0000000000000338
doi: 10.1097/igc.0000000000000338 pubmed: 25514349
Yamada K, Kogure N, Ojima H (2022) Learning curve for robotic bedside assistance for rectal cancer: application of the cumulative sum method. J Robot Surg 16(5):1027–1035. https://doi.org/10.1007/s11701-021-01322-4
doi: 10.1007/s11701-021-01322-4 pubmed: 34779988
Ambinder D, Wang S, Siddiqui MM (2022) Determining the component-based operative time learning curve for robotic-assisted radical prostatectomy. Curr Urol 16(4):240–245. https://doi.org/10.1097/cu9.0000000000000119
doi: 10.1097/cu9.0000000000000119 pubmed: 36714228 pmcid: 9875207
Panico G, Mastrovito S, Campagna G et al (2023) Robotic docking time with the Hugo™ RAS system in gynecologic surgery: a procedure independent learning curve using the cumulative summation analysis (CUSUM). J Robot Surg 17(5):2547–2554. https://doi.org/10.1007/s11701-023-01693-w
doi: 10.1007/s11701-023-01693-w pubmed: 37542580 pmcid: 10492716
Gueli Alletti S, Chiantera V, Arcuri G et al (2022) Introducing the new surgical robot HUGO™ RAS: system description and docking settings for gynecological surgery. Front Oncol 12:898060. https://doi.org/10.3389/fonc.2022.898060
doi: 10.3389/fonc.2022.898060 pubmed: 35756633 pmcid: 9218341
Sarchi L, Mottaran A, Bravi CA et al (2022) Robot-assisted radical prostatectomy feasibility and setting with the Hugo™ robot-assisted surgery system. BJU Int 130(5):671–675. https://doi.org/10.1111/bju.15819
doi: 10.1111/bju.15819 pubmed: 35689414
Mottaran A, Bravi CA, Sarchi L et al (2023) Robot-assisted sacropexy with the novel HUGO robot-assisted surgery system: initial experience and surgical setup at a tertiary referral robotic center. J Endourol 37(1):35–41. https://doi.org/10.1089/end.2022.0495
doi: 10.1089/end.2022.0495 pubmed: 36053673
Bianchi PP, Salaj A, Rocco B, Formisano G (2023) First worldwide report on Hugo RAS™ surgical platform in right and left colectomy. Updates Surg 75(3):775–780. https://doi.org/10.1007/s13304-023-01489-5
doi: 10.1007/s13304-023-01489-5 pubmed: 36897505
Quijano Y, Vicente E, Ferri V, Naldini C, Pizzuti G, Caruso R (2023) Robot-assisted Nissen fundoplication with the new HUGO™ Robotic assisted system: First worldwide report with system description, docking settings and video. Int J Surg Case Rep 106:108178. https://doi.org/10.1016/j.ijscr.2023.108178
doi: 10.1016/j.ijscr.2023.108178 pubmed: 37060760 pmcid: 10139878
Rottoli M, Cardelli S, Calini G, Alexa ID, Violante T, Poggioli G (2024) Outcomes of robotic surgery for inflammatory bowel disease using the Medtronic Hugo™ Robotic-Assisted Surgical platform: a single centre experience. Int J Colorectal Dis. https://doi.org/10.21203/rs.3.rs-4618724/v1
Belyaev O, Fahlbusch T, Slobodkin I, Uhl W (2024) Major colorectal surgery with Hugo™ RAS: initial experience of a German center and a review of the literature. Updat Surg. https://doi.org/10.1007/s13304-024-01939-8
doi: 10.1007/s13304-024-01939-8

Auteurs

Matteo Rottoli (M)

Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy. matteo.rottoli2@unibo.it.
Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Via Massarenti 9, 40138, Bologna, Italy. matteo.rottoli2@unibo.it.

Tommaso Violante (T)

School of General Surgery, Alma Mater Studiorum- University of Bologna, Bologna, Italy.
Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, USA.

Giacomo Calini (G)

Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy. giacomo.calini2@unibo.it.
Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Via Massarenti 9, 40138, Bologna, Italy. giacomo.calini2@unibo.it.

Stefano Cardelli (S)

Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.

Marco Novelli (M)

Department of Statistics, Alma Mater Studiorum - University of Bologna, Bologna, Italy.

Gilberto Poggioli (G)

Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH